Reconciling the apparently contrasting observational and genetic evidence on the association between MASLD and cardiovascular disease [0.03%]
遗传学和观察性研究中慢性肾脏病与心血管疾病关联的矛盾证据的一致性分析
Martijn C G J Brouwers
Martijn C G J Brouwers
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH [0.03%]
人工智能数字病理在MASH纤维化评分中对病理学家的辅助作用
Desiree Abdurrachim,Serene Lek,Charlene Zhi Lin Ong et al.
Desiree Abdurrachim et al.
Background & aims: Intra and inter-pathologist variability poses a significant challenge in metabolic dysfunction-associated steatohepatitis (MASH) biopsy evaluation, leading to suboptimal selection of patients and confou...
Poor long-term outcome in patients with porto-sinusoidal vascular disease (PSVD): fact or disease misclassification? [0.03%]
肝 Porto-窦样血管病（PSVD）的长期预后不良：事实还是疾病误分类？
Pierre-Emmanuel Rautou,Heloïse Giudicelli-Lett,Marta Magaz et al.
Pierre-Emmanuel Rautou et al.
Exploring the effects of serum G-CSF levels in acute-on-chronic liver failure (ACLF): Insights from a post-hoc analysis of the GRAFT study [0.03%]
急性肝衰竭患者血清G-CSF水平的临床意义：来自 graft 研究的事后分析
Lena Maria Greverath,Fausto Andreola,Rajiv Jalan et al.
Lena Maria Greverath et al.
Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease [0.03%]
代谢异常与酒精性肝病（MetALD）的专家共识声明
Juan Pablo Arab,Luis Antonio Díaz,Jürgen Rehm et al.
Juan Pablo Arab et al.
This position statement explores the intricate relationship between alcohol intake and metabolic dysfunction in the context of the 2023 nomenclature for steatotic liver disease (SLD). Recent and lifetime alcohol use should be accurately ass...
Practice Guideline
Journal of hepatology. 2024 Nov 26:S0168-8278(24)02728-4. DOI:10.1016/j.jhep.2024.11.028 2024
Human albumin administration at the time of large volume paracentesis: a modified Delphi study [0.03%]
人血白蛋白在大量腹水抽吸时的应用：改良德尔菲研究
Yassin Magdy Ibrahim,Elliot Benjamin Tapper,Joost Ph Drenth et al.
Yassin Magdy Ibrahim et al.
Towards more consistent models and consensual terminology in preclinical research for Steatotic Liver Disease [0.03%]
肝脂肪变性疾病的转化医学模型及统一术语的制定
Abraham S Meijnikman,Marcos F Fondevila,Marco Arrese et al.
Abraham S Meijnikman et al.
Steatotic liver disease (SLD) is one of the most prevalent liver conditions globally and a leading cause of liver transplantation, yet therapeutic advancements have not kept pace with its major impact on global morbidity and mortality. This...
Elisa Allen,Rhiannon Taylor,Alex Gimson et al.
Elisa Allen et al.
Corrigendum to: "A disease-promoting role of the intestinal mycobiome in non-alcoholic fatty liver disease" [J Hepatol (2022) 765-767] [0.03%]
关于“肠道真菌群在非酒精性脂肪肝病中促病作用”的勘误[J Hepatol (2022) 765-767]
Wajahat Z Mehal,Robert F Schwabe
Wajahat Z Mehal
Published Erratum
Journal of hepatology. 2024 Nov 22:S0168-8278(24)02623-0. DOI:10.1016/j.jhep.2024.10.004 2024